Clinical Study

Safety Study Of Study Drug 4 Given As A Single Intratympanic Injection In Subjects With Unilateral Meniere?S Disease

Posted Date: May 15, 2019

  • Investigator: Ravi Samy
  • Type of Study: Drug

The purpose of this study is to test the effectiveness and safety of OTO-104 compared to placebo in subjects with Meniere?s disease. A placebo is an inactive substance that looks like OTO-104 but does not contain active drug.OTO-104 contains an active ingredient, called dexamethasone, which is a co

Criteria:

You Are Being Asked To Participate In A Research Study Of An Investigational Drug, Called Oto-104, F

Keywords:

Meniere?S Disease, Vertigo

For More Information:

Becky Reinert
(513)558-1719
gibsonrk@uc.edu


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.